Physical withdrawal in rats tolerant to 9 -tetrahydrocannabinol precipitated by a connabinoid receptor antagonist

Author： Tsou K.   Patrick S.L.   Walker J.M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.280, Iss.3, 1995-07, pp. : 13-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D.   Scates S.M.   Lowe J.A.   Martin B.R.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal

By Skelton Kelly   Gutman David   Thrivikraman K.   Nemeroff Charles   Owens Michael  

Psychopharmacology, Vol. 192, Iss. 3, 2007-06 ,pp. : 385-396

Springer Publishing Company

Access to resources Recommend Favorite

Mecamylamine-precipitated nicotine-withdrawal aversion in rats

By Suzuki T.   Ise Y.   Tsuda M.   Maeda J.   Misawa M.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 281-284

Elsevier

Access to resources Recommend Favorite

Dopamine D 2 receptor antagonists prevent 9 -tetrahydrocannabinol-induced antinociception in rats

By Carta G.   Gessa G.L.   Nava F.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite